Page last updated: 2024-12-07

corydaline

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Corydaline is an alkaloid found in plants of the genus Corydalis. It has been shown to exhibit various pharmacological activities, including anti-inflammatory, antioxidant, and neuroprotective effects. Corydaline's synthesis has been studied through various methods, including extraction from natural sources and chemical synthesis. Its potential applications in medicine and other fields have prompted research into its structure, activity, and potential therapeutic uses. The compound's unique structure and biological activities make it an interesting target for further study.'

FloraRankFlora DefinitionFamilyFamily Definition
CorydalisgenusA plant genus of the family FUMARIACEAE (classified by some in PAPAVERACEAE) that contains isoquinoline alkaloids.[MeSH]PapaveraceaeThe poppy plant family of the order Papaverales, subclass Magnoliidae, class Magnoliopsida. These have bisexual, regular, cup-shaped flowers with one superior pistil and many stamens; 2 or 3 conspicuous, separate sepals and a number of separate petals. The fruit is a capsule. Leaves are usually deeply cut or divided into leaflets.[MeSH]

Cross-References

ID SourceID
PubMed CID101301
CHEMBL ID2165401
CHEBI ID14027
SCHEMBL ID230676
MeSH IDM0421789

Synonyms (50)

Synonym
brn 0096972
13a-beta-berbine, 2,3,9,10-tetramethoxy-13-alpha-methyl-
13abeta-berbine, 2,3,9,10-tetramethoxy-13alpha-methyl-
6h-dibenzo(a,g)quinolizine, 5,8,13,13a-tetrahydro-2,3,9,10-tetramethoxy-13-methyl-, (13s-e)-
CHEBI:14027 ,
2,3,9,10-tetramethoxy-13beta-methyl-13abeta-berbine
(13s,13ar)-2,3,9,10-tetramethoxy-13-methyl-5,8,13,13a-tetrahydro-6h-isoquino[3,2-a]isoquinoline
nsc-298182
ACON1_000349
(+)-corydaline
518-69-4
corydaline ,
ACON0_001192
MEGXP0_000624
C-7350
BRD-K13148078-001-01-2
(13s,13ar)-2,3,9,10-tetramethoxy-13-methyl-6,8,13,13a-tetrahydro-5h-isoquinolino[2,1-b]isoquinoline
5-21-06-00173 (beilstein handbook reference)
08n392l8vx ,
unii-08n392l8vx
S9252
CHEMBL2165401
corydaline [mi]
7,8,13,13.alpha.-tetrahydrocorydaline
6h-dibenzo(a,g)quinolizine, 5,8,13,13a-tetrahydro-2,3,9,10-tetramethoxy-13-methyl-, (13s,13ar)-
(13s,13ar)-5,8,13,13a-tetrahydro-2,3,9,10-tetramethoxy-13-methyl-6h-dibenzo(a,g)-quinolizine
SCHEMBL230676
corydaline, (+/-)-
6muc9717yk ,
(+/-)-corydaline
6h-dibenzo(a,g)quinolizine, 5,8,13,13a-tetrahydro-2,3,9,10-tetramethoxy-13-methyl-, trans-(+/-)-
6h-dibenzo(a,g)quinolizine, 5,8,13,13a-tetrahydro-2,3,9,10-tetramethoxy-13-methyl-, (13r,13as)-rel-
berbine, 2,3,9,10-tetramethoxy-13beta-methyl-, (+/-)-
(13sr,13ars)-5,8,13,13a-tetrahydro-2,3,9,10-tetramethoxy-13-methyl-6h-dibenzo(a,g)-quinolizine
corydaline dl-form [mi]
unii-6muc9717yk
CCG-208480
berbine, 2,3,9,10-tetramethoxy-13.beta.-methyl-, (+/-)-
CS-4248
TCMDC-143075
AC-35003
HY-N0923
DTXSID90199735
AKOS030242363
SR-05000002225-2
sr-05000002225
corydalis a
2,3,9,10-tetramethoxy-13-methylberbine
Q15410920
EX-A6789

Research Excerpts

Overview

Corydaline is a bioactive alkaloid with various antiacetylcholinesterase, antiallergic, and antinociceptive activities found in the medicinal herb Corydalis Tubers. It is a marker compound used for quality control of DA-9701, a prokinetic agent that is currently in clinical trials in Korea for the treatment of functional dyspepsia (FD)

ExcerptReferenceRelevance
"Corydaline is a marker compound used for quality control of DA-9701, a prokinetic agent formulated from extracts of Pharbitidis semen and Corydalis tuber that is currently in clinical trials in Korea for the treatment of functional dyspepsia (FD)."( Effects of corydaline from Corydalis tuber on gastric motor function in an animal model.
Kim, SY; Lee, TH; Son, M, 2010
)
1.47
"Corydaline is a bioactive alkaloid with various antiacetylcholinesterase, antiallergic, and antinociceptive activities found in the medicinal herb Corydalis Tubers. "( Corydaline inhibits multiple cytochrome P450 and UDP-glucuronosyltransferase enzyme activities in human liver microsomes.
Im, SR; Ji, HY; Lee, H; Lee, HS; Liu, KH; Shim, HJ; Son, M, 2011
)
3.25
"Corydaline is a pharmacologically active isoquinoline alkaloid isolated from Corydalis tubers. "( In vitro metabolism of corydaline in human liver microsomes and hepatocytes using liquid chromatography-ion trap mass spectrometry.
Ji, HY; Kim, JH; Kim, KH; Lee, H; Lee, HS; Lee, KR; Shim, HJ; Son, M, 2012
)
2.13

Actions

ExcerptReferenceRelevance
"Corydaline was found to inhibit CYP2C19-catalyzed S-mephenytoin-4'-hydroxylatoin and CYP2C9-catalyzed diclofenac 4-hydroxylation, with K(i) values of 1.7 and 7.0 mM, respectively."( Corydaline inhibits multiple cytochrome P450 and UDP-glucuronosyltransferase enzyme activities in human liver microsomes.
Im, SR; Ji, HY; Lee, H; Lee, HS; Liu, KH; Shim, HJ; Son, M, 2011
)
2.53

Pharmacokinetics

ExcerptReferenceRelevance
" The validated method was successfully applied to a pharmacokinetic study of THP, THB, THC and CDL in rat plasma following oral administration of Jitai tablet."( Development and validation of liquid chromatography-tandem mass spectrometry method for simultaneous determination of four tertiary alkaloids in rat plasma and its application to a pharmacokinetic study.
Jiang, P; Liu, L; Liu, R; Wang, L; Wang, S; Xiang, L; Zhang, W, 2013
)
0.39
" The pharmacokinetic parameters such as half-life (t1/2), mean residence time (MRT) and maximum concentration (Cmax) were determined."( Preclinical pharmacokinetics, tissue distribution and excretion studies of a potential analgesics - corydaline using an ultra performance liquid chromatography-tandem mass spectrometry.
Fu, Z; Li, X; Liang, L; Wang, J; Zhang, Q, 2013
)
0.61
"Few studies describing the pharmacokinetic properties of chlorogenic acid (CA) and corydaline (CRD) which are marker compounds of a new prokinetic botanical agent, DA-9701, have been reported."( Pharmacokinetics of chlorogenic acid and corydaline in DA-9701, a new botanical gastroprokinetic agent, in rats.
Jeong, JS; Jung, JW; Kang, HE; Kim, JM; Lee, HS; Lee, MG; Son, M, 2014
)
0.89
" It has been recommended that preclinical pharmacokinetic studies of natural medicines include both genders."( Gender differences in corydaline pharmacokinetics in rats.
Choi, MR; Jeong, JS; Jung, JW; Kang, HE; Kwon, YS; Son, M, 2015
)
0.73

Compound-Compound Interactions

ExcerptReferenceRelevance
"In order to develop a direct and reliable method for discovering lead compounds from traditional Chinese medicines (TCMs), a comparative online ligand fishing platform was developed using immobilized capillary enzyme reactors (ICERs) in combination with liquid chromatography-mass spectrometry (LC-MS)."( Online screening of acetylcholinesterase inhibitors in natural products using monolith-based immobilized capillary enzyme reactors combined with liquid chromatography-mass spectrometry.
Jiang, Z; Kool, J; Somsen, GW; Wang, L; Wang, Q; Zhang, T; Zhang, Y; Zhao, Y, 2018
)
0.48

Bioavailability

ExcerptReferenceRelevance
" Transportation parameters and permeability coefficients (P(app)) were then calculated, and P(app) values were compared with the reported values for model compounds, propranolol as a well absorbed drug and atenolol as a poor absorbed drug."( [Biotransformation by human intestinal flora and absorption-transportation characteristic in a model of Caco-2 cell monolayer of d-corydaline and tetrahydropalmatine].
Liu, JX; Liu, YZ; Ran, L; Wu, S; Xu, W; Yang, XB; Yang, XW; Yao, CM, 2013
)
0.59
" Incomplete absorption of CA, its decomposition in the gastrointestinal tract, and/or pre-systemic metabolism resulted in extremely low oral bioavailability (F) of CA (0."( Pharmacokinetics of chlorogenic acid and corydaline in DA-9701, a new botanical gastroprokinetic agent, in rats.
Jeong, JS; Jung, JW; Kang, HE; Kim, JM; Lee, HS; Lee, MG; Son, M, 2014
)
0.67
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
isoquinoline alkaloidAny alkaloid that has a structure based on an isoquinoline nucleus. They are derived from the amino acids like tyrosine and phenylalanine.
isoquinolinesA class of organic heteropolycyclic compound consisting of isoquinoline and its substitution derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Sterol 14-alpha demethylaseTrypanosoma cruzi strain CL BrenerIC50 (µMol)79.43280.00101.707010.0000AID1207588
Carnitine O-palmitoyltransferase 1, muscle isoformHomo sapiens (human)IC50 (µMol)79.43280.12594.244010.0000AID1207588
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (6)

Processvia Protein(s)Taxonomy
fatty acid metabolic processCarnitine O-palmitoyltransferase 1, muscle isoformHomo sapiens (human)
fatty acid beta-oxidationCarnitine O-palmitoyltransferase 1, muscle isoformHomo sapiens (human)
carnitine shuttleCarnitine O-palmitoyltransferase 1, muscle isoformHomo sapiens (human)
carnitine metabolic processCarnitine O-palmitoyltransferase 1, muscle isoformHomo sapiens (human)
response to blue lightCarnitine O-palmitoyltransferase 1, muscle isoformHomo sapiens (human)
long-chain fatty acid transportCarnitine O-palmitoyltransferase 1, muscle isoformHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (2)

Processvia Protein(s)Taxonomy
carnitine O-palmitoyltransferase activityCarnitine O-palmitoyltransferase 1, muscle isoformHomo sapiens (human)
protein bindingCarnitine O-palmitoyltransferase 1, muscle isoformHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (2)

Processvia Protein(s)Taxonomy
mitochondrionCarnitine O-palmitoyltransferase 1, muscle isoformHomo sapiens (human)
mitochondrial outer membraneCarnitine O-palmitoyltransferase 1, muscle isoformHomo sapiens (human)
mitochondrionCarnitine O-palmitoyltransferase 1, muscle isoformHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (15)

Assay IDTitleYearJournalArticle
AID697853Inhibition of horse BChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID1167294Inhibition of Clostridium perfringens neuraminidase 4-methylumbelliferyl-alpha-D-Nacetylneuraminic acid sodium salt hydrate as substrate by fluorometry2014Bioorganic & medicinal chemistry, Nov-01, Volume: 22, Issue:21
Neuraminidase inhibitory activities of quaternary isoquinoline alkaloids from Corydalis turtschaninovii rhizome.
AID1167298Inhibition of Clostridium perfringens neuraminidase 4-methylumbelliferyl-alpha-D-Nacetylneuraminic acid sodium salt hydrate as substrate at 100 uM by fluorometry2014Bioorganic & medicinal chemistry, Nov-01, Volume: 22, Issue:21
Neuraminidase inhibitory activities of quaternary isoquinoline alkaloids from Corydalis turtschaninovii rhizome.
AID1167296Inhibition of Influenza A virus H5N1 neuraminidase using 4-methylumbelliferyl-alpha-D-Nacetylneuraminic acid sodium salt hydrate as substrate by fluorometry2014Bioorganic & medicinal chemistry, Nov-01, Volume: 22, Issue:21
Neuraminidase inhibitory activities of quaternary isoquinoline alkaloids from Corydalis turtschaninovii rhizome.
AID697852Inhibition of electric eel AChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID1167295Inhibition of recombinant Influenza A virus H1N1 neuraminidase using 4-methylumbelliferyl-alpha-D-Nacetylneuraminic acid sodium salt hydrate as substrate by fluorometry2014Bioorganic & medicinal chemistry, Nov-01, Volume: 22, Issue:21
Neuraminidase inhibitory activities of quaternary isoquinoline alkaloids from Corydalis turtschaninovii rhizome.
AID736316Permeability of the compound at 100 uM after 4 hrs by PAMPA-BBB assay2013Journal of natural products, Apr-26, Volume: 76, Issue:4
Applicability of a blood-brain barrier specific artificial membrane permeability assay at the early stage of natural product-based CNS drug discovery.
AID1159557Trypanosoma brucei. Primary growth inhibition assay2015Scientific reports, Mar-05, Volume: 5New compound sets identified from high throughput phenotypic screening against three kinetoplastid parasites: an open resource.
AID1159564Intra-macrophage L. donovani assay2015Scientific reports, Mar-05, Volume: 5New compound sets identified from high throughput phenotypic screening against three kinetoplastid parasites: an open resource.
AID1159565Trypanosoma cruzi intracellular imaging assay2015Scientific reports, Mar-05, Volume: 5New compound sets identified from high throughput phenotypic screening against three kinetoplastid parasites: an open resource.
AID1159559Trypanosoma cruzi. Primary growth inhibition assay2015Scientific reports, Mar-05, Volume: 5New compound sets identified from high throughput phenotypic screening against three kinetoplastid parasites: an open resource.
AID1159560Leishmania donovani. Primary growth inhibition assay2015Scientific reports, Mar-05, Volume: 5New compound sets identified from high throughput phenotypic screening against three kinetoplastid parasites: an open resource.
AID1159558TcCYP51 enzymatic inhibition2015Scientific reports, Mar-05, Volume: 5New compound sets identified from high throughput phenotypic screening against three kinetoplastid parasites: an open resource.
AID1159563HepG2 cytotoxicity assay2015Scientific reports, Mar-05, Volume: 5New compound sets identified from high throughput phenotypic screening against three kinetoplastid parasites: an open resource.
AID1159562Trypanosoma brucei growth inhibition luminescent assay2015Scientific reports, Mar-05, Volume: 5New compound sets identified from high throughput phenotypic screening against three kinetoplastid parasites: an open resource.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (31)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (9.68)18.7374
1990's0 (0.00)18.2507
2000's4 (12.90)29.6817
2010's22 (70.97)24.3611
2020's2 (6.45)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 46.18

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index46.18 (24.57)
Research Supply Index3.47 (2.92)
Research Growth Index5.04 (4.65)
Search Engine Demand Index69.20 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (46.18)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (3.23%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other30 (96.77%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]